In lung cancer, Ras association domain family 1A (RASSF1A) and cyclin‐dependent kinase inhibitor 2A (CDKN2A/p16) are the most commonly epigenetically inactivated TSGs.78 This evidence concerns the gene CDKN2A and lung cancer.